英文

1)  Mizuno S, et al
Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis
Digestive Diseases Science 2010, in press
2)  David Y Graham, Masahiro Asaka
Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod
Journal of Gastroenterology 2010, 45:1-8
3)  Ito M, et al.
Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review
Journal of Gastroenterology 2009, 44: 365-71
4)  Miki K, Fujishiro M
Cautions comparison between east and west is necessary in terms of serum pepsinogen test
Digestive Endoscopy 2009, 21: 134-135
5)  Miki K, et al.
Long term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population
Digestive Endoscopy 2009, 21: 78-81
6)  Fukase K, et al.
Eradication of Helicobacter pylori after endoscopic mucosal resection of early gastric cancer reduced the incidence of metachoronous gastric cancer
Lancet 2008, 372: 392-7
7)  Hosokawa O, et al.
Decreased death from gastric cancer by endoscopic screening: Association with a population-based cancer registry
Scandinavian Journal of Gastroenterology 2008, 28: 166-170
8)  Yanaoka K, et al.
Risk of gastric cancer in asymptomatic middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels
International Journal of Cancer 2008, 123: 917-926
9)  Yanaoka K, et al.
Cancer high-risk subjects identified by serum pepsinogen test: outcomes after 10-year follow-up in asymptomatic middle-aged males
Cancer Epidemiology Biomarkers & Prevention 2008, 17: 838-845
10)  Wai K Leung, et al.
Screening for gastric cancer in Asia: current evidence and practice
Lancet Oncology 2008, 9: 279-287
11)  Parthasarathy G, et al.
Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach
Tropical Gastroenterology 2007, 28: 166-170
12)  Qin CAO, et al.
Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies
Chinese Journal of Digestive Diseases 2007, 8: 15-22
13)  Yoshihara M, Watanabe Y, et al.
Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: A case-control study
Scandinavian Journal of Gastroenterology 2007, 42: 760-764
14)  Miki K, Urita Y
Using serum pepsinogens wisely in a clinical practice
Journal of Digestive Diseases 2007, 8: 8-14
15)  Miki K
Gastric cancer screening using the serum pepsinogen test method
Gastric Cancer 2006, 9: 245-253
16)  Sasazuki S, Inoue M, Iwasaki M, et al.
Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study
Cancer Epidemiology Biomarkers & Prevention 2006, 15: 1341-1347
17)  Oishi Y, Kiyohara Y, Kubo M, et al.
The Serum Pepsinogen Test as a Predictor of Gastric Cancer: The Hisayama Study
American Journal of Epidemiology 2006, 163: 629-637
18)  Nomura A.M.Y, Miki K, et al.
Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii
Journal of Infectious Diseases 2005, 191: 2075-2081
19)  Ohata H, Ichinose M, Miki K, et al.
Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography
Cancer Science 2005, 96: 713-720
20)  Ohata H, Ichinose M, et al.
Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer
International Journal of Cancer 2004, 109: 138-143
21)  Dinis-Ribeiro M, Yamaki G, Miki K, et al.
Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening
Journal of Medical Screening 2004, 11: 141-147
22)  Miki K, et al.
Usefulness of gastric cancer screening using the serum pepsinogen test method
American Journal of Gastroenterology 2003, 98: 735-739